Treating Asthma With An Inhalable JAK1 Inhibitor In Preclinical Models

Asthma is the result of a complex and dysregulated immune response in which the bronchial airways become inflamed and constricted. This lead to chest tightness, wheezing, and difficulty breathing. In many cases, these symptoms can be minor and temporary, and they respond well to available medicines, including inhaled corticosteroids, which work by reducing inflammation in the airways, and long-acting beta-agonists, which relax the smooth muscle that lines the airways. However, some of the most severely ill asthma patients do not derive sufficient benefit from these drugs, which is why my team and I are working toward new treatment approaches that target the immunomodulatory pathways that underlie the disease.

A significant subset of asthma cases are driven by the activity of a class of immune signaling proteins called cytokines, specifically interleukin-13 (IL-13), IL-4, IL-5, IL-9, and thymic stromal lymphopoietin (TSLP). Each of these cytokines is responsible for different aspects of asthma pathology, such as smooth muscle contraction, mucus release, and the attraction of inflammatory cells to the bronchial tissue.

IL-4, IL-13, IL-9, and IL-6 all work by turning on a molecular switch inside the cells they act on, a protein tyrosine kinase called Janus kinase 1 (JAK1). Thus, by targeting JAK1, one can suppress the actions of all these cytokines simultaneously. Indeed, preclinical studies have shown that systemic administration of JAK1 inhibitors may be effective, but JAK1 is also associated with adverse side effects that would be unacceptable for long-term therapy in asthma. One way to bypass these problems is to confine JAK1 inhibition to the lungs through the use of an inhalable JAK1 inhibitor.

In a study we recently published in Science Translational Medicine, we described a JAK1 inhibitor with radically different physicochemical properties compared to a traditional orally administered compound. These properties make it ideal for inhaled administration, as they limit exposure of the medicine to the lung but result in rapid clearance elsewhere in the body.

Using this re-designed JAK1 inhibitor, which we call iJAK-381, we showed that local and selective JAK1 inhibition in the lung demonstrated a therapeutic effect in three preclinical asthma models. Specifically, in guinea pigs, whose lung anatomy is more similar to humans compared with mice, iJAK-381 dose-dependently reversed lung pathology as measured by reduction in pulmonary inflammatory cell influx and reduced expression of IL-13-dependent genes. Importantly, we were able to conclusively demonstrate that the activity of iJAK-381 was restricted to the lungs. Thus, lung-restricted JAK1 inhibition is sufficient to inhibit disease in these pre-clinical models.

We’re excited and encouraged by these early results, as they provide some of the first evidence that lung-restricted JAK1 inhibition is sufficient to suppress asthma-related inflammation.

These findings are described in the article entitled Lung-restricted inhibition of Janus kinase 1 is effective in rodent models of asthma, recently published in the journal Science Translational Medicine.

Speak Your Mind!

READ THIS NEXT

Ancient Detectives: How Science Unraveled The Real History Of Dinosaurs

Dinosaurs have been extinct for approximately 65 million years, yet they continue to fascinate and awe people all over the […]

Studies Find That Divide Between Democrats/Republicans “Worst It’s Ever Been”, Voters Willing To Overlook Dishonesty From Their Own Party

A new study out of Michigan State University has found that party polarization could be the worst it’s ever been, […]

Perseid Meteor Shower To Reach Peak August 12-13: Here’s How To See It

This upcoming Sunday and Monday the annual Perseids meteor shower event will reach its luminous peak. Stargazers are predicted to […]

The Effect Of Xenobiotics On Placenta Development In Pregnancy

The placenta constitutes a boundary between the fetal and maternal environments, being involved in the exchange of nutrients and waste […]

How Parental Treatment Shapes Children’s Personalities

The impact that parents have on their children’s personalities continues to be a topic of debate. Children may, on average, […]

White Spider: What Is It And Is It Deadly?

Picture this scenario: you are walking through a field populated with flowers of all colors. As you glance to your […]

Using Fluorescent Indicators In Cancer Cells To Advance Image-guided Cancer Surgery

Accurate visualization is critical for cancer surgery.  A large portion of the Oncologic surgeon’s task is distinguishing normal tissue from […]